Filters
One way how hormone therapy with oestradiol may slow the progression of atherosclerotic cardiovascular disease (CVD) in postmenopausal women is through the reduction of inflammatory biomarkers, according to the ELITE* study presented at the NAMS 2020 Annual Meeting.
Corticosteroids, infliximab, and vedolizumab are all beneficial in the treatment of patients with checkpoint inhibitor‐induced enterocolitis, according to a study.
